Intra-Abdominal Infections Clinical Trial
Official title:
Tygacil Drug Use Investigation (Tigecycline Evaluation Study For Safety And Effectiveness In Patient Infected With Multi-Drug Resistance.)
Secondary Data Collection Study; safety and effectiveness of Tigecycline .under Japanese medical practice
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT04240288 -
Procalcitonin Guided Antibiotic Therapy
|
N/A | |
Completed |
NCT01431326 -
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
|
||
Completed |
NCT01473836 -
A Phase 3 Study Of Intravenous Metronidazole For Intrabdominal Infection
|
Phase 3 | |
Terminated |
NCT03354754 -
LYS228 PK, Clinical Response, Safety and Tolerability in Patients With Complicated Intra-abdominal Infection (cIAI)
|
Phase 2 | |
Completed |
NCT00965848 -
A Safety and Efficacy Study of Doripenem in Participants With Nosocomial Pneumonia, Complicated Intra-Abdominal Infections and Urinary Tract Infections
|
Phase 4 | |
Completed |
NCT01506271 -
Study of the Safety, Tolerability, and Efficacy of Relebactam (MK-7655) + Imipenem/Cilastatin Versus Imipenem/Cilastatin Alone to Treat Complicated Intra-Abdominal Infection [cIAI] (MK-7655-004)
|
Phase 2 | |
Completed |
NCT05628493 -
Gut Microbiota Analysis in IAI Patients With Sepsis-associated Liver Dysfunction
|
||
Completed |
NCT02442596 -
Abdominal SepsiS Study: Epidemiology of Etiology and Outcome
|
N/A | |
Recruiting |
NCT04094818 -
HostDx Sepsis in the Diagnosis and Prognosis of Emergency Department Patients With Suspected Infections and Suspected Sepsis
|
||
Withdrawn |
NCT05639504 -
Sepsis Prognosis and Diagnosis in the Emergency Department (SPEED)
|
||
Completed |
NCT00827541 -
Post-Authorization Study Evaluating Safety Of Tigecycline
|
N/A |